PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
02-Feb-2024 Tisotumab Vedotin Marketing Authorization Application Validated by European Medicines Agency for Treatment of Recurrent or Metastatic Cervical Cancer Businesswire
02-Feb-2024 Asia-Pacific Functional Genomics Market: Analysis and Forecasts 2023-2033: Collaborations Foster Innovations, Efficient Instruments Shape the Future of the Landscape - ResearchAndMarkets.com Businesswire
02-Feb-2024 KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Businesswire
02-Feb-2024 Zura Bio Announces Participation at February Investor Conferences Businesswire
02-Feb-2024 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
02-Feb-2024 Napp announces authorisation of REZZAYO® (rezafungin) in Great Britain by the UK Medicines and Healthcare Products Regulatory Agency for the treatment of invasive candidiasis in adults Napp Pharmaceuticals Limited
02-Feb-2024 Riassunto: Delta-Fly Pharma Inc.: avviso di avvio dello studio clinico comparativo pivotale di fase III di DFP-14323 Businesswire
02-Feb-2024 Samenvatting: Delta-Fly Pharma Inc.: kennisgeving van initiatie van cruciale vergelijkende klinische studie Fase III van DFP-14323 Businesswire
02-Feb-2024 Power and Stability: Highly reliable CW Raman Fiber Amplifier CW Raman
02-Feb-2024 Krones at Anuga FoodTec 2024 Krones at Anuga FoodTec 2024
02-Feb-2024 FY23 Trading Update & NEDs Appointment Dowgate Capital
02-Feb-2024 Aston University appoints new associate dean of law Aston University
02-Feb-2024 EMS Healthcare appoints Dr Clare Grace as Chief Executive Officer EMS
02-Feb-2024 The ABPI sets out its plan for investment, health and growth ABPI
02-Feb-2024 TME Pharma Announces Final Median Overall Survival Data Reaching 19.9 Months for NOX-A12 Combination Regimen in GLORIA Brain Cancer Trial and Survival Rate 10-Fold Greater Than Standard of Care Businesswire
02-Feb-2024 Delta-Fly Pharma Inc.: Notice of Initiation of Phase III Pivotal comparative clinical trial of DFP-14323 Businesswire
02-Feb-2024 Domrex Pharma Inc. Expands Presence in the United States Businesswire
02-Feb-2024 Ligand Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Businesswire
02-Feb-2024 Baron & Budd Named to U.S. News & World Report 2024 Best Companies to Work For: Law Firms Businesswire
02-Feb-2024 Ted Love, MD, Joins Gilead Sciences’ Board of Directors Businesswire